INTERCEPT Program of circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) in colorectal cancer (CRC): Results from a prospective clinical cohort.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Giulia Maddalena, Andrew Jared Pellatt, Madhulika Eluri, Christine Megerdichian Parseghian, Kathryn Aziz, Kristin Alfaro, Robert J. Kell, Alisha Heather Bent, Ryan W Huey, Abhineet Uppal, Tsuyoshi Konishi, Michael J. Overman, Maria Pia Morelli, Jason Willis, John Paul Y.C. Shen, Kanwal Pratap Singh Raghav, Timothy E. Newhook, Van K. Morris, Arvind Dasari, Scott Kopetz
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4391091075